2016
DOI: 10.1590/0001-3765201620150760
|View full text |Cite
|
Sign up to set email alerts
|

Atheroprotective action of a modified organoselenium compound: in vitro evidence

Abstract: Oxidation of low-density lipoprotein (LDL) has been strongly suggested to play a significant role in the pathogenesis of atherosclerosis. Thus, reducing LDL oxidation is a potential approach to decrease the risk of the atherosclerosis. Organoselenium compounds have demonstrated promising atheroprotective properties in experimental models. Herein, we tested the in vitro atheroprotective capability of a modified organoselenium compound, Compound HBD, in protecting isolated LDL from oxidation as well as foam cell… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 68 publications
0
3
0
Order By: Relevance
“…In the present study, bixin and lycopene exhibited a concentration-dependent inhibition of Cu 2+ -induced lipid peroxidation in isolated human LDL by reducing the rate of oxidation. The lag phase is indicative of the inherent resistance of LDL to oxidation and is widely utilized to assess the potential anti-atherogenic properties of compounds [3,29,46].…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, bixin and lycopene exhibited a concentration-dependent inhibition of Cu 2+ -induced lipid peroxidation in isolated human LDL by reducing the rate of oxidation. The lag phase is indicative of the inherent resistance of LDL to oxidation and is widely utilized to assess the potential anti-atherogenic properties of compounds [3,29,46].…”
Section: Discussionmentioning
confidence: 99%
“…Such athero-protective effect was also confirmed for another GPX-mimicking organoselenium compound, HBD, in in vitro experiments on murine macrophages. HBD application protected isolated LDL from Cu 2+ -induced oxidation and decreased the foam cell formation in macrophage culture exposed to oxLDL [52].…”
Section: Reduction Of Foam Cell Formation By Sementioning
confidence: 92%
“…In the same paper, the authors also discussed the beneficial effects of selenium in animal models of Parkinson's disease, a severe neurodegenerative disease. Moreover, Oliveira et al (2016) demonstrated that the organoselenium compound HBD is atheroprotective by preventing Cu 2+ -induced oxidation of lowdensity lipoprotein (LDL), the main factor that causes atherosclerosis (Spence 2016). …”
mentioning
confidence: 99%